CNMD · CONMED Corp · Documents

Aug 2

Current report 8-K Events of Aug 1

Entered into a material agreement, New debt or off-balance-sheet obligation, Regulation FD disclosure

Jul 28

Quarterly report 10-Q FY2022 Q2, ended Jun 30

Quarterly report for FY2022 Q2

Revenue $277.19M ▲ 8.6% Net loss $168.29M Diluted EPS -$5.65

Jul 27

Earnings call

Q2 2022 earnings call

Jul 27

Current report 8-K

Financial results

Jun 13

Current report 8-K

Completed an acquisition or sale of assets, Regulation FD disclosure

Jun 7

Current report 8-K Events of Jun 6

Entered into a material agreement, New debt or off-balance-sheet obligation, Unregistered sale of equity, Other events

Jun 2

Current report 8-K Events of Jun 1

Other events

May 31

Current report 8-K

Other events

May 26

Current report 8-K Events of May 24

Shareholder vote results, Other events

May 5

Current report 8-K Events of May 4

Entered into a material agreement

May 5

Quarterly report 10-Q FY2022 Q1, ended Mar 31

Quarterly report for FY2022 Q1

Revenue $242.33M ▲ 4.1% Net income $14.98M ▲ 51.9% Diluted EPS $0.47 ▲ 51.6%

May 4

Earnings call

Q1 2022 earnings call

May 4

Current report 8-K

Financial results, Regulation FD disclosure

Apr 15

Proxy statement DEF 14A Meeting May 25, 2022

Proxy statement

Apr 15

Proxy statement DEFA14A

Proxy statement

Mar 7

Current report 8-K Events of Mar 5

Director or officer change, or executive pay

Feb 28

Current report 8-K

Other events

Feb 22

Annual report 10-K FY2021, ended Dec 31

Annual report for FY2021

Revenue $1.01B ▲ 17.2% Net income $62.54M ▲ 557.2% Diluted EPS $1.94 ▲ 506.3%

Jan 26

Earnings call

Q4 2021 earnings call

Jan 26

Current report 8-K

Financial results

Nov 29

Current report 8-K

Other events

Oct 28

Quarterly report 10-Q FY2021 Q3, ended Sep 30

Quarterly report for FY2021 Q3

Revenue $248.83M ▲ 4.6% Net income $14.95M ▲ 118.2% Diluted EPS $0.47 ▲ 104.3%

Oct 27

Earnings call

Q3 2021 earnings call

Oct 27

Current report 8-K

Financial results

Aug 12

Current report 8-K

Other events

Jul 29

Quarterly report 10-Q FY2021 Q2, ended Jun 30

Quarterly report for FY2021 Q2

Revenue $255.16M ▲ 61.7% Net income $13.29M Diluted EPS $0.41

Jul 28

Earnings call

Q2 2021 earnings call

Jul 28

Current report 8-K

Financial results

Jul 16

Current report 8-K

Entered into a material agreement, New debt or off-balance-sheet obligation

May 20

Current report 8-K Events of May 19

Shareholder vote results, Other events

Apr 29

Quarterly report 10-Q FY2021 Q1, ended Mar 31

Quarterly report for FY2021 Q1

Revenue $232.68M ▲ 8.7% Net income $9.86M ▲ 66.4% Diluted EPS $0.31 ▲ 55.0%

Apr 28

Earnings call

Q1 2021 earnings call

Apr 28

Current report 8-K

Financial results

Apr 19

Current report 8-K Events of Apr 15

Other events

Apr 9

Proxy statement DEF 14A Meeting May 19, 2021

Proxy statement

Apr 9

Proxy statement DEFA14A

Proxy statement

Feb 23

Current report 8-K

Other events

Feb 22

Annual report 10-K FY2020, ended Dec 31

Annual report for FY2020

Revenue $862.46M ▼ 9.7% Net income $9.52M ▼ 66.7% Diluted EPS $0.32 ▼ 67.0%

Jan 27

Earnings call

Q4 2020 earnings call

Jan 27

Current report 8-K

Financial results

Nov 23

Current report 8-K Events of Nov 20

Entered into a material agreement, New debt or off-balance-sheet obligation

Nov 13

Current report 8-K

Other events

Oct 29

Quarterly report 10-Q FY2020 Q3, ended Sep 30

Quarterly report for FY2020 Q3

Revenue $237.84M ▲ 1.8% Net income $6.85M ▼ 1.7% Diluted EPS $0.23 ▲ unchanged

Oct 28

Earnings call

Q3 2020 earnings call

Oct 28

Current report 8-K

Financial results

Oct 1

Current report 8-K Events of Sep 29

Director or officer change, or executive pay

Aug 14

Current report 8-K Events of Aug 13

Other events

Jul 30

Quarterly report 10-Q FY2020 Q2, ended Jun 30

Quarterly report for FY2020 Q2

Revenue $157.79M ▼ 33.8% Net loss $27.4M Diluted EPS -$0.96

Jul 29

Earnings call

Q2 2020 earnings call

Jul 29

Current report 8-K

Financial results